View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

   reports
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 45.67
600161 Beijing Tiantan...
BAYN Bay National Co...

Vermilion Int'l Compass: Global Equity Strategy

Defensives Worthy of a Tactical Overweight As recently as last week (March 30 Int'l Compass) and throughout February/March we have recommended shifting to defensives due to our belief that $93 will cap upside on the MSCI ACWI (ACWI-US) in 2023. MSCI ACWI defensive Sectors including Health Care, Utilities, and Consumer Staples are hitting 2+ month RS highs, and are staging bullish price and RS reversals, as are precious metals miners (GDX-US). This confirms our belief that now is the time to be ...

600161 BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED CLASS A
BAYN BAY NATIONAL CORP.
04/06/23 April 6, 2023 1 EN
LXS LANXESS AG

Moody's announces completion of a periodic review of ratings of Lanxes...

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Lanxess AG. Global Credit Research- 17 Oct 2019. Frankfurt am Main, October 17, 2019-- Moody's Investors Service has completed a periodic review of the ratings of Lanxess AG and other ratings that are associated with the same analytical unit.

10/17/19 October 17, 2019 4 EN
ROG Roche Holding L...
SNYN SANOFI S.A. ADS ... (+8)

Moody's: China's rising demand for drugs will fuel foreign pharma comp...

Announcement: Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023. Global Credit Research- 24 Sep 2019. -Relaxed regulation, improving healthcare coverage to drive China's pharmaceutical demand.

ROG ROCHE HOLDING LTD
SNYN SANOFI S.A. ADS
NOVA NOVO NORDISK A/S ADS
BMY BRISTOL-MYERS SQUIBB COMPANY
NVS.. NOVARTIS AG ADS
PFE PFIZER INC.
AZN ASTRAZENECA PLC
BAYN BAY NATIONAL CORP.
09/25/19 September 25, 2019 4 EN
ROG Roche Holding L...
SNYN SANOFI S.A. ADS ... (+8)

Moody's: China's rising demand for drugs will fuel foreign pharma comp...

Announcement: Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023. Global Credit Research- 24 Sep 2019. -Relaxed regulation, improving healthcare coverage to drive China's pharmaceutical demand.

ROG ROCHE HOLDING LTD
SNYN SANOFI S.A. ADS
NOVA NOVO NORDISK A/S ADS
BMY BRISTOL-MYERS SQUIBB COMPANY
NVS.. NOVARTIS AG ADS
PFE PFIZER INC.
AZN ASTRAZENECA PLC
BAYN BAY NATIONAL CORP.
09/24/19 September 24, 2019 4 EN
EUR 228.35
BAYN Bay National Co...

Bayer AG: Update to credit analysis

Our credit view of Bayer following H1 results release, asset disposals and in light of glyphosate litigation.

BAYN BAY NATIONAL CORP.
09/02/19 September 2, 2019 13 EN
EUR 685.05
BAYN Bay National Co...

Bayer AG - June 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

BAYN BAY NATIONAL CORP.
08/28/19 August 28, 2019 2 EN
EUR 182.68
BAYN Bay National Co...

Bayer AG: Sale of Animal Health business to Elanco is credit positive

Bayer will receive around $5.3 billion in cash (pre-tax) and Elanco shares worth $2.3 billion in exchange for its Animal Health business. We expect use of proceeds for deleveraging.

BAYN BAY NATIONAL CORP.
08/20/19 August 20, 2019 4 EN
EUR 182.68
LXS LANXESS AG
BAYN Bay National Co...

Bayer AG & Lanxess AG: Disposal of chemical park operator Currenta is ...

The sale will yield net proceeds of around €1.1 billion for Bayer, which it could use to deleverage, and around €625 million for Lanxess, which it might use to make acquisitions.

LXS LANXESS AG
BAYN BAY NATIONAL CORP.
08/07/19 August 7, 2019 3 EN
EUR 182.68
BAYN Bay National Co...

Bayer AG: Bayer upholds 2019 guidance with qualifications, setting bar...

Weaker Crop Science activities in first half sets the bar higher to achieve full-year guidance.

BAYN BAY NATIONAL CORP.
07/31/19 July 31, 2019 4 EN
Research Department
  • Research Department
BMW BAYERISCHE MOTOREN WERKE AG
ANA ACCIONA SA
IBE IBERDROLA SA
SAN BANCO SANTANDER S.A.
TL5 MEDIASET ESPANA COMUNICACION SA
UNI UNICAJA BANCO S.A.
BAYN BAY NATIONAL CORP.
BNP BMW
AEDAS AEDAS HOMES SA
VOW VOLKSWAGEN (VOW GR)
DBK DAIMLER (DAI GR)
07/03/19 July 3, 2019 12 ES
EUR 182.68
BAYN Bay National Co...

Bayer AG: Beefing up its governance is a positive move

New board committee and outside advisor focused on glyphosate litigation underpins Bayer's determination to effectively deal with the glyphosate complex.

BAYN BAY NATIONAL CORP.
06/28/19 June 28, 2019 3 EN
EUR 685.05
LXS LANXESS AG

Lanxess AG - March 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

06/20/19 June 20, 2019 2 EN
EUR 685.05
BAYN Bay National Co...

Bayer AG - March 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

BAYN BAY NATIONAL CORP.
05/30/19 May 30, 2019 2 EN
BAYN Bay National Co...

Moody's - Bayer’s credit quality able to withstand hypothetical EUR...

Scenario outcomes range from Bayer maintaining its credit quality to a marked deterioration

BAYN BAY NATIONAL CORP.
04/30/19 April 30, 2019 4 EN
EUR 685.05
BAYN Bay National Co...

Bayer AG: Scenario Analysis: Hypothetical glyphosate settlement of up ...

Scenario outcomes range from Bayer maintaining its credit quality to a marked deterioration

BAYN BAY NATIONAL CORP.
04/30/19 April 30, 2019 6 EN
EUR 685.05
LXS LANXESS AG

Lanxess AG - December 2018 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

04/25/19 April 25, 2019 2 EN
EUR 685.05
BAYN Bay National Co...

Bayer AG - December 2018 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

BAYN BAY NATIONAL CORP.
04/08/19 April 8, 2019 2 EN
Jean-Jacques Le Fur
  • Jean-Jacques Le Fur
PREMIUM
BAYN BAYER AG
Bay National Co...

BAYER - SELL | EUR66(+9%) Glyphosate litigation: moving towards a sett...

BAYER - SELL | EUR66(+9%) Glyphosate litigation: moving towards a settlement? US District Judge may ask Bayer to begin mediation A multibillion dollar settlement The weakness of Bayer is not only glyphosate litigation

BAYN BAYER AG
BAY NATIONAL CORP.
04/05/19 April 5, 2019 3 EN
Eric Monnier ... (+2)
  • Eric Monnier
  • Jean-Jacques Le Fur
PREMIUM
BAYN Bay National Co...

BAYER: Q4 2018 results slightly better than expected | NEUTRAL | EUR81

BAYER - NEUTRAL | EUR81(+19%) Q4 2018 results slightly better than expected A significantly better Q4 2018 than expected for Crop Science Pharmaceuticals slightly sales below consensus Consumer Health remains in the tunnel Crop Science is the focus

BAYN BAY NATIONAL CORP.
02/27/19 February 27, 2019 3 EN
EUR 228.35
BAYN Bay National Co...

Bayer AG: Update to credit analysis

Our credit view of Bayer post the Monsanto acquisition, restructuring announcement, new 2022 targets and glyphosate litigation

BAYN BAY NATIONAL CORP.
02/13/19 February 13, 2019 12 EN
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest
Save

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search
Save

ResearchPool Subscriptions

Get the most out of your insights

Get in touch